Pro Medicus Secures $33M North American Contract in Healthcare Imaging

Pro Medicus secures a $33M, 9-year contract with the University of Kentucky to implement the Visage 7 platform.

  • The deal includes a comprehensive solution with Visage 7 Viewer, Workflow, and Open Archive modules.
  • The agreement reinforces Pro Medicus’ growing influence in the North American healthcare IT sector.
  • Pro Medicus will replace legacy PACS and archive systems, enhancing imaging capabilities and operational efficiency at UK HealthCare.

Pro Medicus Limited (ASX: PME) is a leading Australian healthcare informatics company, founded in 1983. Specialising in medical imaging software and services, it offers a comprehensive range of solutions to hospitals, imaging centres, and healthcare providers worldwide. In 2009, Pro Medicus acquired Visage Imaging, establishing itself as a global leader in medical imaging. Its flagship Visage 7 platform provides ultra-fast, clinically rich, and scalable solutions, compatible with both public and private cloud environments. The company’s suite of offerings includes RIS, PACS, AI, and e-health solutions, with offices in Melbourne, Berlin, and San Diego.

Growth Pipeline: Securing Long-Term Contracts with Leading Healthcare Providers

Pro Medicus Limited, a leader in healthcare imaging technology, continues its impressive expansion with a significant new contract. The company has secured a $33 million, nine-year deal with the University of Kentucky (UK) HealthCare, which will see its advanced Visage 7 Enterprise Imaging Platform implemented across the healthcare system. This deal, underscoring Pro Medicus’ growing footprint in the North American healthcare market, highlights the company’s ability to deliver cutting-edge cloud-based solutions to academic and clinical institutions.

The University of Kentucky partnership is a key addition to Pro Medicus’ expanding portfolio of high-value contracts with academic and healthcare institutions in North America. This deal, worth $33 million, follows a series of other successful agreements, including a $330 million contract with Trinity Health and a $30 million agreement with Duly Health and Care. These partnerships not only strengthen Pro Medicus’ position in North America but also provide a robust pipeline for future growth.

The University of Kentucky HealthCare network includes a range of hospitals and clinics, with the UK Albert B. Chandler Hospital being a key medical facility. UK HealthCare is also affiliated with the University of Kentucky College of Medicine, making it a hub for research, education, and advanced medical care. With Pro Medicus now integrated into this esteemed healthcare network, the company is set to further solidify its reputation as a global leader in healthcare informatics.

Pro Medicus’ strategic focus on the academic healthcare sector provides it with a competitive advantage. The partnership with the University of Kentucky marks the company’s third significant contract in this segment, further confirming its standing as a preferred partner for large-scale healthcare institutions.

Cloud Strategy: Emphasising CloudPACS in Academic Institutions

Pro Medicus’ CloudPACS strategy is at the heart of its growth, and the University of Kentucky contract showcases how the company is leveraging its cloud-first architecture to meet the evolving needs of healthcare providers. Cloud-based solutions are becoming increasingly vital in the healthcare sector, driven by the demand for greater scalability, speed, and seamless integration across systems.

The Visage 7 platform will replace UK HealthCare’s legacy Picture Archiving and Communication System (PACS) and vendor-neutral archive systems. By moving to a fully cloud-based solution, the University of Kentucky will benefit from a more efficient and integrated imaging platform that improves diagnostic workflows and enhances operational efficiency across its network of hospitals and clinics.

This trend is a clear indication of the healthcare industry’s shift towards integrated cloud technologies. Pro Medicus’ innovative solutions are positioned to capitalise on this transformation, making its technology highly attractive to academic health systems that require scalable, reliable, and efficient imaging capabilities.

Financial Performance: Strong Shareholder Returns

Pro Medicus’ financial performance has been a key driver of its growth, and the company continues to deliver impressive returns for its shareholders. Over the past year, Pro Medicus has seen its share price increase by an astounding 163.33%, reflecting the company’s strong growth trajectory and strategic focus on the healthcare IT sector.

With a market capitalisation of $26.44 billion, Pro Medicus is now one of the top companies listed on the Australian Securities Exchange. The company’s solid financial performance is a testament to its ability to secure long-term contracts and its continued expansion into international markets.

The $33 million University of Kentucky deal is expected to deliver a significant revenue stream over the next nine years, further solidifying Pro Medicus’ financial position. This contract, along with other recent agreements, underscores the company’s growing dominance in the healthcare imaging sector and its ability to execute on its strategic initiatives.

Style

Motors

Living

Business

Previous and Next Articles
Trending Articles
Travel

The Ritz Carlton Lodge Marks a New Chapter in Experiential Luxury in Australia

The arrival of The Ritz-Carlton Lodge signals a defining moment for luxury hospitality in Australia. Known globally for refined service and timeless elegance, The Ritz-Carlton introduces a new lodge concept that reimagines luxury through immersion, nature and cultural connection. This opening reflects a growing desire for experiences that feel grounded, restorative and deeply meaningful. Rather than replicating […]

30th January 2026
Fashion

Moncler Is Turning Milan-Cortina 2026 Into a Global Skiwear Showcase

30th January 2026
Fashion

Schiaparelli and the Art of Surreal Couture in the Modern Age

28th January 2026
Food & Drink

The Macallan 72 Years Old in Lalique Genesis Decanter

28th January 2026

REACH YOUR FULL POTENTIAL

Ready to elevate yourgame to new heights? Look no further!

By submitting your details below, you’ll gain exclusive access to the finest content in investment and lifestyle from KODARI Magazine. Whether you’re seeking insights into luxury living, expert investment insights, or the latest trends in high-end fashion and travel, we’ve got you covered.